ID   DMBi001-A-1
AC   CVCL_A7LC
DR   BioSamples; SAMEA8770928
DR   hPSCreg; DMBi001-A-1
DR   Wikidata; Q107114814
RX   PubMed=34509921;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6482; LAMA2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC40 ! DMBi001-A
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
RX   PubMed=34509921; DOI=10.1016/j.scr.2021.102529;
RA   Jelinkova S., Martyniak A., Dulak J., Stepniewski J.;
RT   "Derivation of human pluripotent stem cell line via CRISPR/Cas9
RT   mediated deletion of exon 3 LAMA2 gene (DMBi001-A-1).";
RL   Stem Cell Res. 56:102529-102529(2021).
//